US 11660352
Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof
granted A61KA61K47/6811A61K47/6849
Quick answer
US patent 11660352 (Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K47/6811, A61K47/6849, A61K47/6851, A61K47/6879